|Colliers Securities LLC||Kyle Bauser, Ph.D., Managing Director|
|Echelon Partners||Andrew Semple|
|Stansberry Research||Thomas Carroll|
|Viridian Capital||Jon Decourcey|
MariMed Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding MariMed Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MariMed Inc. or its management. MariMed Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.